In a new study published in JAMA Network Open, researchers at Thomas Jefferson University have developed a novel screening tool to measure digital health readiness, which will be critical in addressing barriers to telehealth adoption among diverse patient populations.
CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board – Biotech Investments
Issuer: CureVac / Key word(s): Personnel 15.08.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Names Oncologist and